Clinical trial
Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or…
NCT00020787 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00020787 |
|---|---|
| Title | Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer |
| Official title | An Open Label, Sequential Multi-Center Multi Dose Study Of G17T Immunogen In Combination With Cisplatin (CDDP) And 5-Fluorouracil (5-FU) In Subjects With Metastatic Or Locally Recurrent Gastric Or Gastroesophageal Cancer Previously Untreated With Chemotherapy For Advanced Disease (Stage IV) |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Gastric Cancer |
| Intervention type | Biological, Drug |
| Interventions | G17DT Immunogen, cisplatin, fluorouracil |
| Enrollment | 8 |
| Start date | Jul 1, 2001 |
| Primary completion | Jan 1, 2002 |
| Completion | Dec 1, 2002 |
| First posted | Jan 8, 2004 |
| Last update posted | Aug 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: